The interaction of secreted phospholipase A2-IIA with the microbiota alters its lipidome and promotes inflammation
Secreted phospholipase A2-IIA (sPLA2-IIA) hydrolyzes phospholipids to liberate lysophospholipids and fatty acids. Given its poor activity toward eukaryotic cell membranes, its role in the generation of proinflammatory lipid mediators is unclear. Conversely, sPLA2-IIA efficiently hydrolyzes bacterial membranes. Here, we show that sPLA2-IIA affects the immune system by acting on the intestinal microbial flora. Using mice overexpressing transgene-driven human sPLA2-IIA, we found that the intestinal microbiota was critical for both induction of an immune phenotype and promotion of inflammatory arthritis. The expression of sPLA2-IIA led to alterations of the intestinal microbiota composition, but housing in a more stringent pathogen-free facility revealed that its expression could affect the immune system in the absence of changes to the composition of this flora. In contrast, untargeted lipidomic analysis focusing on bacteria-derived lipid mediators revealed that sPLA2-IIA could profoundly alter the fecal lipidome. The data suggest that a singular protein, sPLA2-IIA, produces systemic effects on the immune system through its activity on the microbiota and its lipidome.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
JCI insight - 7(2022), 2 vom: 25. Jan. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Doré, Etienne [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Arthritis |
|---|
| Anmerkungen: |
Date Completed 22.03.2022 Date Revised 22.03.2022 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1172/jci.insight.152638 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM336105223 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM336105223 | ||
| 003 | DE-627 | ||
| 005 | 20231225231359.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1172/jci.insight.152638 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1120.xml |
| 035 | |a (DE-627)NLM336105223 | ||
| 035 | |a (NLM)35076027 | ||
| 035 | |a (PII)e152638 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Doré, Etienne |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The interaction of secreted phospholipase A2-IIA with the microbiota alters its lipidome and promotes inflammation |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.03.2022 | ||
| 500 | |a Date Revised 22.03.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Secreted phospholipase A2-IIA (sPLA2-IIA) hydrolyzes phospholipids to liberate lysophospholipids and fatty acids. Given its poor activity toward eukaryotic cell membranes, its role in the generation of proinflammatory lipid mediators is unclear. Conversely, sPLA2-IIA efficiently hydrolyzes bacterial membranes. Here, we show that sPLA2-IIA affects the immune system by acting on the intestinal microbial flora. Using mice overexpressing transgene-driven human sPLA2-IIA, we found that the intestinal microbiota was critical for both induction of an immune phenotype and promotion of inflammatory arthritis. The expression of sPLA2-IIA led to alterations of the intestinal microbiota composition, but housing in a more stringent pathogen-free facility revealed that its expression could affect the immune system in the absence of changes to the composition of this flora. In contrast, untargeted lipidomic analysis focusing on bacteria-derived lipid mediators revealed that sPLA2-IIA could profoundly alter the fecal lipidome. The data suggest that a singular protein, sPLA2-IIA, produces systemic effects on the immune system through its activity on the microbiota and its lipidome | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Arthritis | |
| 650 | 4 | |a Inflammation | |
| 650 | 4 | |a Microbiology | |
| 650 | 4 | |a Molecular pathology | |
| 650 | 4 | |a Mouse models | |
| 650 | 7 | |a Group II Phospholipases A2 |2 NLM | |
| 650 | 7 | |a EC 3.1.1.4 |2 NLM | |
| 700 | 1 | |a Joly-Beauparlant, Charles |e verfasserin |4 aut | |
| 700 | 1 | |a Morozumi, Satoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Mathieu, Alban |e verfasserin |4 aut | |
| 700 | 1 | |a Lévesque, Tania |e verfasserin |4 aut | |
| 700 | 1 | |a Allaeys, Isabelle |e verfasserin |4 aut | |
| 700 | 1 | |a Duchez, Anne-Claire |e verfasserin |4 aut | |
| 700 | 1 | |a Cloutier, Nathalie |e verfasserin |4 aut | |
| 700 | 1 | |a Leclercq, Mickaël |e verfasserin |4 aut | |
| 700 | 1 | |a Bodein, Antoine |e verfasserin |4 aut | |
| 700 | 1 | |a Payré, Christine |e verfasserin |4 aut | |
| 700 | 1 | |a Martin, Cyril |e verfasserin |4 aut | |
| 700 | 1 | |a Petit-Paitel, Agnes |e verfasserin |4 aut | |
| 700 | 1 | |a Gelb, Michael H |e verfasserin |4 aut | |
| 700 | 1 | |a Rangachari, Manu |e verfasserin |4 aut | |
| 700 | 1 | |a Murakami, Makoto |e verfasserin |4 aut | |
| 700 | 1 | |a Davidovic, Laetitia |e verfasserin |4 aut | |
| 700 | 1 | |a Flamand, Nicolas |e verfasserin |4 aut | |
| 700 | 1 | |a Arita, Makoto |e verfasserin |4 aut | |
| 700 | 1 | |a Lambeau, Gérard |e verfasserin |4 aut | |
| 700 | 1 | |a Droit, Arnaud |e verfasserin |4 aut | |
| 700 | 1 | |a Boilard, Eric |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JCI insight |d 2016 |g 7(2022), 2 vom: 25. Jan. |w (DE-627)NLM257703918 |x 2379-3708 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2022 |g number:2 |g day:25 |g month:01 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1172/jci.insight.152638 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2022 |e 2 |b 25 |c 01 | ||